Background: Antibiotic resistance is an issue of concern to physicians, scientists and patients. It has an impact on the increase of morbidity, length of hospital stay and mortality of patients. There is also a correlation between the resistance of bacteria to antibiotics and their geographical location. Objective: Analysis of the prevalence of nosocomial skin and soft tissue infection pathogens and the rate of development of antimicrobial resistance in the Siberian and Far Eastern regions of Russia. Methods: Data on microbial antimicrobial susceptibility and prevalence of major genetic determinants of antimicrobial resistance were analyzed. The work was carried out on the basis of data from the AMRmap online platform. Comparison of indicators was based on samples obtained from adult surgical patients with infected skin and soft tissues throughout 2016-2020 in the Siberian and Far Eastern regions of Russia. Results: 5 microorganisms were identified in adult surgical patients with infected skin and soft tissues on the territory of the Siberian region and the Far Eastern region (Russia) in 2016-2020. They were Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Acinetobacter baumannii. The authors used the AMRmap online platform to study the sensitivity and resistance to various antibacterial drugs applied to the three most important pathogens in the regions. Conclusions: The results indicate a rapid spread of resistance genes in the studied strains of Klebsiella pneumoniae, P. aeruginosa, S. aureus, E. coli, Acinetobacter baumannii. Systems for monitoring resistance to antibacterial drugs by laboratory methods need to be improved. It is also necessary to create new databases and improve the existing ones. These will help to select the optimal drug treatment strategy for patients according to their resistance profile.
BACKGROUND: Antibiotics have helped people to treat many diseases and have made the treatment of patients much easier. However, due to the development of resistance factors, antibiotics have become less effective against bacteria. Antimicrobial resistance is one of today's most important issues in global medicine. OBJECTIVE: to determine the expression of cephalosporin drug resistance in an inpatient setting. METHODS: This study was conducted at the Clinical Hospital of Emergency Medical Care Tver, Russia, for the period 2018-2020. Using the standard method of bacteriological examination, the microbiome of 624 patients was examined. The next step was to determine the level of antibiotic resistance. RESULTS: Microorganisms of different spectrum, including Pseudomonas aeruginosa, Escherichia coli, Acinetobacter, etc., were isolated from clinical samples during the study. All microorganism groups showed decreased susceptibility to the drugs used in the study. Ceftriaxone (a third-generation cephalosporin) had the greatest loss of potency (reduction to 0% for all isolates in the study). Cefoperazone sulbactam and ceftazidime rapidly lost activity in this study. Increasing resistance to cefepime (a fourth-generation cephalosporin) was observed. CONCLUSIONS. The study results indicate the rapid spread of resistance among a wide range of pathogenic microorganisms to the studied cephalosporin groups. Complete resistance developed within three years to the third-generation cephalosporins. A decrease in the susceptibility to the fourth generation of cephalosporins was observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.